Cargando…
Guillain-Barré syndrome in a patient with multiple myeloma after bortezomib therapy: A case report
BACKGROUND: Bortezomib is a first-line drug approved for patients with multiple myeloma (MM) and has significantly increased their overall survival. However, bortezomib-induced peripheral neuropathy (PN) remains a significant side effect that has led to its discontinuation in some patients. Guillain...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789385/ https://www.ncbi.nlm.nih.gov/pubmed/31616710 http://dx.doi.org/10.12998/wjcc.v7.i18.2905 |